Melanoma Immunotherapy Solutions
Appleglc.com illuminates melanoma treatment pathways including BRAF-targeted therapy, immune checkpoint inhibitors, and TIL therapies — helping patients reclaim hope and health.
Amtagvi
Lifileucel
Tecentriq
Atezolizumab
Tecentriq Hybreza
Atezolizumab and Hyaluronidase-tqjs
Mektovi
Binimetinib
Braftovi
Encorafenib
Cotellic
Cobimetinib Fumarate
Tafinlar
Dabrafenib Mesylate
DTIC-Dome
Dacarbazine
Hepzato
Melphalan Hydrochloride
Imlygic
Talimogene Laherparepvec
Intron A
Recombinant Interferon Alfa-2b
Yervoy
Ipilimumab
Keytruda
Pembrolizumab
Kimmtrak
Tebentafusp-tebn
Mekinist
Trametinib Dimethyl Sulfoxide
Opdivo
Nivolumab
Opdivo Qvantig
Nivolumab and Hyaluronidase-nvhy
Opdualag
Nivolumab and Relatlimab-rmbw
Proleukin
Aldesleukin
Zelboraf
Vemurafenib
Aldesleukin IV
Aldesleukin
Lifileucel TIL Therapy
Lifileucel
Atezolizumab IV
Atezolizumab
Atezolizumab SC
Atezolizumab and Hyaluronidase-tqjs
Binimetinib
Binimetinib
Encorafenib
Encorafenib
Cobimetinib
Cobimetinib Fumarate
Dabrafenib
Dabrafenib Mesylate
IL-2
Aldesleukin
Interleukin-2
Aldesleukin
Ipilimumab IV
Ipilimumab
Alkeran
Melphalan Hydrochloride
Nivolumab IV
Nivolumab
Nivolumab SC
Nivolumab and Hyaluronidase-nvhy
Nivolumab/Relatlimab IV
Nivolumab and Relatlimab-rmbw
Pembrolizumab IV
Pembrolizumab
Imlygic IV
Talimogene Laherparepvec
Tebentafusp Infusion
Tebentafusp-tebn
Trametinib
Trametinib Dimethyl Sulfoxide
Vemurafenib
Vemurafenib